Patents by Inventor Allison R. Ficht

Allison R. Ficht has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hydrogel condom
    Patent number: 11291750
    Abstract: A hydrogel condom containing an antioxidant can provide increased sexual pleasure, thus improving usage and resulting in prevention of disease and prevention of unwanted pregnancies.
    Type: Grant
    Filed: February 23, 2017
    Date of Patent: April 5, 2022
    Assignee: THE TEXAS A&M UNIVERSITY SYSTEM
    Inventors: Mahua Choudhury, Xiaofeng Kang, Allison R. Ficht
  • Use of vitelline protein B as a microencapsulating additive
    Patent number: 10952970
    Abstract: The present invention includes compositions and methods for the use of an encapsulation additive having between about 0.1 to about 30 percent isolated and purified vitelline protein B to provide for mixed and extended release formulations.
    Type: Grant
    Filed: January 26, 2017
    Date of Patent: March 23, 2021
    Assignees: THE TEXAS A&M UNIVERSITY SYSTEM, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Allison R. Ficht, Kenneth Carson, Cynthia Sheffield, John Herbert Waite
  • Use of Vitelline Protein B as a Microencapsulating Additive
    Publication number: 20170135958
    Abstract: The present invention includes compositions and methods for the use of an encapsulation additive having between about 0.1 to about 30 percent isolated and purified vitelline protein B to provide for mixed and extended release formulations.
    Type: Application
    Filed: January 26, 2017
    Publication date: May 18, 2017
    Inventors: Allison R. Ficht, Kenneth Carson, Cynthia Sheffield, John Herbert Waite
  • Use of vitelline protein B as a microencapsulating additive
    Patent number: 9555073
    Abstract: The present invention includes compositions and methods for the use of an encapsulation additive having between about 0.1 to about 30 percent isolated and purified vitelline protein B to provide for mixed and extended release formulations.
    Type: Grant
    Filed: February 28, 2012
    Date of Patent: January 31, 2017
    Assignees: THE TEXAS A&M UNIVERSITY SYSTEM, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Allison R. Ficht, Ken Carson, Cynthia Sheffield, John Herbert Waite
  • Controlled release vaccines and methods for treating diseases and disorders
    Patent number: 9248176
    Abstract: Methods and compositions for the treatment of Brucella induced diseases and disorders are disclosed herein. In preferred embodiments, the invention relates to vaccines. In additional embodiments, the invention relates to formulations capable of releasing said vaccines at a controlled rate of release in vivo. In further embodiments, the invention relates to modified strains of the bacteria Brucella melitensis and Brucella abortus. In still further embodiments, the invention relates to compositions that do not induce clinical symptoms or splenomegaly in a subject receiving said compositions.
    Type: Grant
    Filed: October 7, 2011
    Date of Patent: February 2, 2016
    Assignee: THE TEXAS A&M UNIVERSITY SYSTEM
    Inventors: Thomas A. Ficht, Allison R. Ficht, Renee Tsolis, Leslie Garry Adams
  • Use of Vitelline Protein B as a Microencapsulating Additive
    Publication number: 20120156287
    Abstract: The present invention includes compositions and methods for the use of an encapsulation additive having between about 0.1 to about 30 percent isolated and purified vitelline protein B to provide for mixed and extended release formulations.
    Type: Application
    Filed: February 28, 2012
    Publication date: June 21, 2012
    Applicant: THE TEXAS A&M UNIVERSITY SYSTEM
    Inventors: Allison R. Ficht, Ken Carson, Cynthia Sheffield, John Herbert Waite